Vatican Confirms Pope Leo XIV Needs No More Lung Cancer Treatment

The Vatican has officially announced that Pope Leo XIV will not require any further medical intervention for lung cancer, following a successful surgical procedure that effectively removed the cancerous tissue. This positive update was disclosed by the Vatican press office in a medical bulletin issued on Wednesday. The announcement came after the conclusion of tests on tissue samples extracted during the pontiff's surgery, which took place last week.

According to the bulletin, the final histological reports and molecular biology analyses confirmed that the disease was a pulmonary adenocarcinoma and was entirely localized. The bulletin stated unequivocally: “The results have confirmed that the condition was a pulmonary adenocarcinoma and that the disease was localized. A subsequent oncological evaluation has confirmed that no further therapy is required.” Pulmonary adenocarcinoma stands as the most common form of lung cancer, accounting for approximately 40 percent of all cases. It frequently affects non-smokers and typically exhibits a relatively slow progression.

Pope Leo had initially revealed on October 11 that he needed surgery for a lung nodule, a disclosure that generated considerable concern both within and outside the Vatican. Subsequently, medical professionals successfully removed the affected lobe of his left lung during his hospitalization in Rome. He was discharged and returned to his home on October 17. The very next day, the pontiff made his first public appearance since his diagnosis, leading the Sunday Angelus prayer from the balcony of the Apostolic Palace. Reflecting on his personal health journey, Leo shared with worshippers, “This experience has given me a profound sense of closeness to all those who are going through illness or a state of infirmity.”

CNN reported that the Pope’s recovery process has been remarkably swift, surpassing typical expectations for such surgical procedures. The report cited Dr. Juanita Mora, a national medical spokesperson for the American Lung Association, who, although not directly involved in his treatment, offered insights. Dr. Mora indicated that doctors would likely continue to monitor the pontiff through follow-up CT scans every three to six months during the initial years, followed by annual checks to identify any potential recurrence. She also highlighted that patients recovering from such surgery frequently undergo respiratory physiotherapy to aid in restoring their breathing capacity.

This encouraging announcement from the Vatican comes ahead of the Pope’s scheduled South American tour next month, which is slated to include visits to Peru, Uruguay, and Argentina, necessitating at least 14 flights. While the Vatican has yet to officially confirm the trip's final arrangements, Professor Stefano Margaritora, the lead surgeon for the operation, informed Vatican News that he sees “no clinical reasons” for its cancellation. Dr. Mora advised that the Pope might be encouraged to walk during the long flights to help prevent blood clots. Additionally, she recommended that he receive COVID-19, influenza, and respiratory syncytial virus vaccines for enhanced protection against respiratory infections. The Vatican’s latest update confirms that while no further cancer treatment is presently required, ongoing medical follow-up is anticipated to remain a crucial aspect of the pontiff's recovery journey.